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1. Introduction
  Sansevieria liberica (S. liberica) (family Agavaceae, 
Ruscaceae or Dracaenaceae), is one of the bowstring 
hemp species[1], with concave, short petioled leaves that 
are in part transversely banded with light and dark green, 
also linearly striated with whitish to light green and dark 
green striations[2]. This plant has long rhizomes with long 
fibrous roots and a rapid rate of growth. The fruit is a red or 
orange berry. It is a rather stout herb with several stiff red-
margined leaves about 2 feet high arising from the creeping 
plant, and 50-80 cm long inflorescence (longer than the 
leaves) with abundant white flowers. They are grown as 
ornamental plants[3], and are widely distributed throughout 
the tropics. Their leaves are very rich in fibers[4,5], 
protein[5], potassium, calcium, magnesium, vitamin C, 
biotin, and riboflavin[6]. The leaves also contain alkaloids, 
allicins, carotenoids, flavonoids, glycosides, saponins 
and tannins[5,7]. Fibers for local use are obtained from the 
leaves in various countries for making string, nets, coarse 
fabrics and bows. Osabohien[8] reported that bowstring 
hemp fiber produced appreciable reinforcement of natural 
rubber, though inferior to CB(N330) filler, but gave harder 
vulcanizates. In traditional health care practice, the leaves 
are used as pain killers, and in the treatment of small pox, 
chicken pox, measles and most venereal diseases. The 
pressed juice of the leaves is dropped in the eyes and ears 
for the treatment of infections and inflammations. The fumes 
from the burning leaves are inhaled to relieve feverish 
headaches and cold. A decoction of the roots is drunk as 
a remedy for convulsions and as a vermifuge. In Nigeria, 
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the leaves and roots of S. liberica are used in traditional 
health care practice for the treatment of asthma, abdominal 
pains, colic, diarrhea, eczema, gonorrhea, hemorrhoids, 
hypertension, diabetes mellitus, monorrhagia, piles, sexual 
weakness, wounds of the foot, and alleviating the effects 
of snake bites[4,8-11]. The hypotensive effect of aqueous 
extract of the leaves[12], as well as their ability to moderate 
hematological indices and plasma chemistry in salt-loaded 
rats[13], has been reported. The present study investigated 
the effects of an aqueous extract of the leaves of S. liberica 
on hematology, plasma biochemistry and ocular indices of 
oxidative stress in alloxan-induced diabetic Wistar rats
2. Materials and methods
2.1. Chemicals
  All chemicals used were of analytical grade.
2.2. Preparation of plant extract
  Samples of fresh S. liberica plants (Figure 1) were 
procured from a horticultural garden by Air Force Gate, 
Aba Road, Port Harcourt, and another at the University of 
Port Harcourt’s Abuja campus, University of Port Harcourt, 
Port Harcourt, Nigeria. After due identification at the 
University of Port Harcourt Herbarium, Port Harcourt, 
the identity was confirmed/authenticated by Dr. Michael 
C. Dike of Taxonomy Unit, Department of Forestry and 
Environmental Management, Michael Okpara University 
of Agriculture, Umudike, Abia State, Nigeria; and Mr. John 
Ibe, the Herbarium Manager of the Forestry Department, 
National Root Crops Research Institute (NRCRI), Umuahia, 
Nigeria. They were rid of dirt and the leaves were removed, 
oven dried at 55  曟 and ground into powder. The resultant 
powder was soaked in hot, boiled distilled water for 12 h,
after which the resultant mixture was filtered and the 
filtrate, hereinafter referred to as the aqueous extract was 
stored in the refrigerator for subsequent use. A known 
volume of this extract was evaporated to dryness, and the 
weight of the residue used to determine the concentration of 
the filtrate, which was in turn used to determine the dose of 
administration of the extract.
Figure 1. S. liberica.
2.3. Experimental design
  Wistar albino rats (weighing 180-205 g at the start of 
the study) were obtained from the animal house of the 
Department of Physiology, University of Nigeria, Enugu 
Campus. Studies were conducted in compliance with the 
applicable laws and regulations for handling experimental 
animals. The rats were weighed and sorted into nine groups 
(Table 1) of five animals each, so that their average weights 
were approximately equal. The animals were housed in 
plastic cages at the animal house of the Department of 
Biochemistry, University of Port Harcourt. After a one-
week acclimatization period on guinea growers mash (Port 
Harcourt Flour Mills, Port Harcourt, Nigeria), the animals 
were fasted overnight, and their baseline fasting blood 
glucose level determined using a glucometer, by collecting 
blood via tail cut. Diabetes was induced by injection of a 
freshly prepared solution of alloxan (80 mg/kg body weight) 
in normal saline, via the tail vein of six groups, while the 
control rats were injected with normal saline alone. The 
dosage of administration of alloxan was adopted from 
Radwan[14]. Three days after administration of the alloxan, 
the animals were again fasted and blood collected via 
tail cutting blood[15], for the determination of their fasting 
glucose levels.  It was found that the rats had moderate 
diabetes, having hyperglycemia (that is, with blood glucose 
of over 180% of the control). Then the rats were kept for
Table 1.
Experimental design for the anti-diabetic screening.
S/N ID Treatment
1 Normal Normal saline and water
2 Test control Alloxan and water
3 Reference treatment (Reference) Alloxan and metformin (50 mg/kg body weight)
4 Treatment control I (LLC1) Normal saline and extract (100 mg/kg)
5 Treatment control II (LLC2) Normal saline and extract (200 mg/kg)
6 Treatment control III (LLC3) Normal saline and extract (300 mg/kg)
7 Treatment I (LL1) Alloxan and extract (100 mg/kg)
8 Treatment II (LL2) Alloxan and extract (200 mg/kg)
9 Treatment III (LL3) Alloxan and extract (300 mg/kg)
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3 d to stabilize the diabetic condition[16] before commencing 
the treatment, which lasted for ten days. The DiabetminTM 
(metformin HCl) and extracts were administered daily by 
intra-gastric gavages. The dosages of administration of 
the extracts were adopted and modified from Ikewuchi 
et al[12,13]. The animals were allowed food and water ad 
libitum. The fasting glucose levels were taken on days 5 
and 10. The animals were allowed normal feed and water 
ad libitum. At the end of the treatment period, the rats were 
weighed, fasted overnight and anaesthetized by exposure to 
chloroform. While under anesthesia, they were painlessly 
sacrificed and blood was collected from each rat into heparin 
and EDTA sample bottles. Whole blood was immediately 
used to determine the triglyceride levels (using multiCarein 
strips). Then the eyes were removed and stored for the 
determination of the ocular markers of oxidative stress. The 
heparin anti-coagulated blood samples were centrifuged at 
1 000 g for 10 min, after which their plasma was collected 
and stored for subsequent analysis, while the EDTA anti-
coagulated blood samples were used for the hematological 
analysis.
2.4. Determination of the plasma biochemical indices
  The plasma glucose concentration was determined 
using the multiCareinTM glucose strips and glucometer 
(Biochemical Systems International, Arezzo, Italy). 
Plasma triglyceride concentration was determined using 
multiCareinTM triglyceride strips and glucometer. Plasma 
total and high density lipoprotein cholesterol concentrations 
were assayed enzymatically with Randox commercial test 
kits (Randox Laboratories Ltd., Crumlin, England, UK). In the 
presence of magnesium ions, low density lipoproteins (LDL 
and VLDL) and chylomicrons fractions were precipitated 
quantitatively by the addition of phosphotungstic acid. After 
centrifugation, the cholesterol concentration of the high 
density lipoprotein (HDL) fraction, which remained in the 
supernatant, was determined, as in total cholesterol. The 
cholesterol released by enzymatic hydrolysis was oxidized 
with the concomitant release of hydrogen peroxide, whose 
breakdown led to the conversion of 4-aminoantipyridine 
to quinoneimine (the indicator) whose concentration was 
determined spectrophotometrically at 500 nm.
  Plasma VLDL- and LDL-cholesterol concentrations were 
calculated using the Friedewald equation[17] as follows:
[LDL cholesterol] (mmol/L)
     =[Total cholesterol]-[HDL cholesterol]-                               [Eqn 1]
[Triglyceride]
2.2
[LDL cholesterol] (mmol/L)=                                                       [Eqn 2]
[Triglyceride]
2.2
  While the plasma non-HDL cholesterol concentration was 
determined as reported by Brunzell et al[18]:
[Non-HDL cholesterol]=[Total cholesterol]-[HDL cholesterol]      [Eqn 3]
  The atherogenic indices were calculated as earlier reported 
by Ikewuchi and Ikewuchi[19,20,21] using the following 
formulae:
Cardiac Risk Ratio (CRR)=                                                        [Eqn 4]
[Total Cholesterol]
[HDL cholesterol]
Atherogenic Coefficient (AC)=                                                                     [Eqn 5]
[Total cholesterol]-[HDL cholesterol]
[HDL cholesterol]
Atherogenic Index of Plasma (AIP)=log                                      [Eqn 6]
[Triglyceride]
[HDL cholesterol]
  The plasma activities of alanine and aspartate 
transaminases, and alkaline phosphatase, were determined 
using Randox test kits (Randox Laboratories Ltd., Crumlin, 
England, UK). The activities of alanine and aspartate 
transaminases were respectively measured by monitoring 
at 546 nm, the concentrations of pyruvate and oxaloacetate 
hydrazones formed with 2,4-dinitrophenylhydrazine. 
The activity of alkaline phosphatase was determined by 
monitoring the degradation of p-nitrophenylphosphate to 
p-nitrophenol, at 405 nm. 
  Plasma total and conjugated bilirubin, urea and creatinine 
concentrations were determined using Randox test kits 
(Randox Laboratories Ltd., Crumlin, England, UK). The 
wavelength for the determination of conjugated bilirubin 
and urea was 546 nm and that of total bilirubin was 578 nm. 
Plasma total protein was determined by the Biuret method 
Table 2.
Effects of an aqueous extract of the leaves of S. liberica leaves on the plasma glucose profiles of normal and alloxan treated rats.
Treatment group Day 0 (mg/dL)
Day 5 Day 10
Value (mg/dL) Reduction (%) Value (mg/dL) Reduction (%)
Normal    96.00依2.92a    98.35依4.46a,d   -2.61依7.29a 104.20依5.07a  -8.73依8.17a
Test control   155.40依5.73c,e  208.00依5.10c,* -33.94依4.13c   179.50依8.20c,* -15.67依7.36a
Reference 125.90依1.95d     89.33依2.10d,e,*   29.05依0.64d     110.00依7.52a,d,*   12.56依6.88c
LLC1   83.20依9.86b     89.40依8.62b,d,e      -7.99依10.19a,e     91.80依6.98e,* -10.84依6.91a
LLC2  78.75依5.31b       94.00依7.65a,d,e,*  -19.62依10.03e      94.40依5.68b,e,* -20.18依8.92a
LLC3  99.00依4.00a     89.60依9.04a,d,e      9.41依9.25e,f  102.80依8.87a,b   -3.99依9.92a
LL1 137.40依9.53d   109.33依8.64b,f,*     20.08依9.11d,f  112.00依3.46d,*   18.16依6.38c
LL2 153.33依7.85e   88.67依7.12e,*    41.89依7.42b       99.00依4.90a,b,e,*   35.36依3.15b
LL3 144.20依9.31c  104.33依7.74a,f,*    27.58依4.27d  119.80依6.34d,*   16.58依7.68c
Values are mean依s.d., n=5, per group. a,bValues in same column with different superscripts letters are significantly different at P<0.05. *P<0.05 
compared to corresponding values on day 0. Reduction (%) = percentage reduction from the corresponding values on day 0.
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using Randox test kits, and the concentration of the resultant 
colored complex was measured at 560 nm.
  Plasma sodium and potassium concentration was 
determined by flame photometry, according to AOAC 
Official Method 956.01[22]. Plasma calcium concentration 
was determined by the cresol phthalein complexone 
method[23], and the concentration of the resultant complex 
was measured at 575 nm. Plasma chloride and bicarbonate 
concentrations were determined by titrimetric methods[24].
2.5. Determination of the hematological indices
  Hematological indices were determined using Medonic M16 
Hematological Analyser (Nelson Biomedical Limited., UK).
2.6. Determination of ocular indices of oxidative stress
  Each eye was homogenized in 4 mL of 1 mmol/L phosphate 
buffer (pH 7.4). The resultant homogenate was centrifuged at 
1 000 g for 15 min, and the supernatants were collected and 
stored in the refrigerator for the assays. The protein contents 
of the homogenates were determined by the biuret method, 
using Randox test kits.
  The method adopted for the analysis of malondialdehyde 
was that of Hunter et al[25] as modified by Gutteridge 
and Wilkins[26]. The concentration of the resultant 
malondialdehyde - thiobarbituric acid complex (or adduct) 
was measured at 532 nm. Ascorbic acid content was 
estimated by iodine titration as reported by Ikewuchi and 
Ikewuchi[27], and Ikewuchi et al[28]. Catalase activity was 
determined according to the method of Beers and Sizer[29]. 
The concentration of the residual hydrogen peroxide 
was measured at 420 nm. Superoxide dismutase activity 
was determined according to the method of Misra and 
Fridovich[30]. The degree of inhibition of the auto-oxidation 
of adrenaline (which reflects the activity of superoxide 
dismutase) was determined by measuring the concentration 
of the resultant adrenochrome, at 520 nm. The amount of 
enzyme that produced 50% inhibition was defined as one 
unit of the enzyme activity.
2.7. Statistical analysis of data
  All values are reported as the mean依s.d. (standard 
deviation). The values of the variables were analysed for 
statistically significant differences using the Student’s 
t-test, with the help of SPSS Statistics 17.0 package (SPSS 
Inc., Chicago Ill). P<0.05 was assumed to be significant.
3. Results
  The time course of the hypoglycemic effect of an aqueous 
extract of the leaves of S. liberica on normal and alloxan-
induced diabetic rats is presented in Table 2. On day 0, 
the plasma fasting glucose concentration of the alloxan 
treated animals were significantly higher (P<0.05) than the 
untreated animals (normal, LLC1, LLC2 and LLC3). On days 
Table 3.
Effects of an aqueous extract of the leaves of S. liberica on the plasma lipid profile of normal and alloxan treated rats.
Treatment group
Concentration  (mmol/L)
Triglyceride Total cholesterol HDL cholesterol VLDL cholesterol LDL cholesterol Non-HDL cholesterol
Normal 0.84依0.09a 1.74依0.08a 1.11依0.04a 0.38依0.04a   0.25依0.10a,d   0.63依0.11a,d
Test control 1.04依0.06c 2.24依0.14c 0.71依0.05c 0.48依0.03c 1.06依0.12c 1.53依0.10c
Reference 0.88依0.03a   1.89依0.12a,b 1.24依0.07c 0.40依0.02a 0.25依0.08d 0.65依0.07d
LLC1  1.00依0.15a,c   1.90依0.16a,b   1.09依0.15a,c   0.45依0.07a,c   0.36依0.02a,e 0.81依0.06a
LLC2 0.87依0.08a 1.89依0.07b 1.21依0.03c 0.40依0.04a    0.28依0.10a,d,f   0.68依0.09a,d
LLC3  1.00依0.14a,c 1.92依0.13b   1.19依0.07a,c   0.46依0.07a,c 0.28依0.05d   0.73依0.07a,d
LL1  1.04依0.09c 1.82依0.05b 0.87依0.05e 0.47依0.04c  0.47依0.10e,f 0.94依0.08e
LL2   0.91依0.12a,c 2.24依0.09c 1.10依0.04a   0.41依0.06a,c 0.73依0.10b 1.15依0.10b
LL3 0.62依0.02b 2.15依0.08c 1.07依0.06a 0.28依0.01b 0.80依0.07b 1.08依0.07b
Values are mean依s.d., n=5, per group. a,bValues in same column with different superscripts are significantly different at P<0.05.
Table 4.
Effects of an aqueous extract of the leaves of S. liberica on the atherogenic indices of normal and alloxan treated rats.
Treatment group Cardiac risk ratio Atherogenic coefficient Atherogenic index of plasma
Normal 1.57依0.11a,d 0.57依0.11a,d -0.12依0.05a
Test control 3.17依0.15c 2.17依0.15c   0.17依0.05c
Reference 1.53依0.06d 0.53依0.06d -0.15依0.04a
LLC1 1.75依0.12a 0.75依0.12a -0.04依0.08a,b,e
LLC2 1.57依0.09a,d 0.57依0.09a,d -0.14依0.04a,b
LLC3 1.61依0.05a,d 0.61依0.05a,d -0.08依0.06a,b
LL1 2.09依0.15b 1.09依0.15b   0.08依0.03e
LL2 2.05依0.10b 1.05依0.10b -0.08依0.07b
LL3 2.01依0.09b 1.01依0.09b -0.24依0.03d
Values are mean依s.d., n=5, per group. a,bValues in same row with different superscripts are significantly different at P<0.05.
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5 and 10, the plasma fasting glucose levels of the animals 
administered the extracts were significantly lower (P<0.05) 
than corresponding test controls and values on day 0. The 
percentage reductions in plasma fasting glucose levels of 
the treated rats on days 5 and 10, were significantly higher 
(P<0.05) than the corresponding values of the test control 
group.
  The effects of an aqueous extract of the leaves of S. liberica 
on the plasma lipid profiles of normal and alloxan-induced 
diabetic rats is shown in Table 3. The plasma triglyceride 
and very low density lipoprotein cholesterol levels of the test 
control group were significantly higher (P<0.05) than those 
of control, reference, LLC2 and LL3, but not significantly 
different from those of LLC1, LLC3, LL1 and LL2. The 
plasma total cholesterol level of the test control group was 
significantly higher (P<0.05) than those of control, reference, 
LLC1, LLC2, LLC3 and LL1, but not significantly higher than 
those of LL1 and LL2. The plasma high density lipoprotein 
cholesterol level of the test control group was significantly 
lower (P<0.05) than those of all the other groups. The plasma 
low density lipoprotein and non-high density lipoprotein 
cholesterol levels of the test control group were significantly 
Table 5.
Effects of an aqueous extract of S. liberica leaves on plasma hepatospecific markers of normal and alloxan treated rats
Treatment group
Magnitude
A l k a l i n e 
phosphatase 
activity
 (U/L)
A l a n i n e 
transaminase 
activity
 (U/L)
A s p a r t a t e 
transaminase 
activity 
(U/L)
Total bilirubin 
(毺mol/L)
C o n j u g a t e d 
bilirubin
(毺mol/L)
Unconjugated 
bilirubin 
(毺mol/L)
Unconjugated 
/ c o n j u g a t e d 
bilirubin ratio
Total protein 
(mg/dL)
Normal 176.64依2.75a 13.66依0.82a 21.58依0.93a 2.93依0.22a,d,e,f 2.27依0.19a,f 0.66依0.12a,e,f,h 0.30依0.06a,c 50.96依1.84a
Test control 567.87依6.40b 26.61依0.88c 27.05依0.77c 3.64依0.21c 2.71依0.22c 0.93依0.04c 0.35依0.04c,d 59.99依0.92c
Reference 316.19依4.49c 21.00依0.63d 25.92依2.04c,d 3.52依0.08c,d 2.21依0.17a,d,f 1.30依0.14d 0.59依0.11e 57.61依0.93d
LLC1 253.00依7.48d 18.87依1.00e,h 17.48依2.88b 3.13依0.04e 2.33依0.04a 0.81依0.01e 0.35依0.01c 55.01依0.79e
LLC2 212.52依4.93e 15.45依0.52f 16.97依0.83b 2.71依0.02f 1.97依0.02b 0.75依0.02f 0.38依0.01d 55.17依0.95e
LLC3 382.41依7.14f 17.62依0.82g,h 22.05依0.76a,e 3.07依0.05e 2.07依0.02f 1.01依0.05g 0.49依0.02b,e 54.00依1.29a,e
LL1 269.56依2.30g 19.18依0.86b,e 23.26依1.02d,e 2.41依0.06b 1.72依0.05e 0.68依0.01h 0.40依0.01b 53.03依1.22a
LL2 388.24依5.51h 18.16依0.81b,g 24.82依0.66d,f 2.84依0.03a 1.97依0.04b,d 0.87依0.02k 0.44依0.02f 64.03依1.66b
LL3 458.80依4.65k 21.54依0.65d 25.67依0.87c,f 3.61依0.07c,d 2.83依0.07c 0.78依0.01b 0.28依0.01a 56.05依1.88d,e
Values are mean依s.d., n=5, per group. a,bValues in same column with different superscripts are significantly different at P<0.05.
Table 6.
Effects of an aqueous extract of S. liberica leaves on the plasma electrolyte profiles of normal and alloxan treated rats.
Treatment group
Concentration
Urea
(mmol/L)
Blood urea nitrogen
(mg/dL)
Calcium
(mmol/L)
Sodium
(mg/dL)
Potassium
(mg/dL)
Chloride
(meq/L)
Bicarbonate
 (meq/L)
Normal 20.70依1.08a,b 58.15依3.03a,b 2.06依0.08a,d,e 129.15依1.82a 5.23依0.07a 98.83依0.84a 18.20依0.84a,d
Test control 28.70依1.01c 80.62依2.82c 1.89依0.06c 148.67依1.75c 5.00依0.07b 84.75依0.43b 15.25依0.50
c
Reference 12.65依0.52d 35.55依1.45d 1.97依0.06a,c,e 130.00依1.58a 9.20依0.10c 114.66依0.85c 18.00依0.71d,e
LLC1 14.39依0.68e 40.41依1.92e 2.09依0.08b,e,g 127.71依1.20a 5.36依0.06d 96.00依0.71d 18.00依0.71d
LLC2 17.73依0.78f 49.81依2.19f 2.03依0.06a,g 129.33依1.47a 4.90依0.07b 102.67依0.41e 17.00依0.71a
LLC3 13.68依0.55e 38.43依1.54e 2.07依0.06b,e 139.40依1.95d 6.68依0.08e 100.60依0.55f 18.00依0.71d
LL1 20.65依0.38a 58.00依1.08a 2.12依0.09b,e 134.33依2.68b,d 5.60依0.07f 88.67依0.41g 16.67依0.41e
LL2 21.17依0.93a 59.46依2.62a 1.96依0.06a 130.00依2.45a,b 6.00依0.07g 98.00依0.71a 21.67依0.41b
LL3 19.00依0.59b 53.37依1.65b 2.11依0.07b,d 129.00依2.55a 5.53依0.04h 97.50依0.50h 19.00依0.71d
Values are mean依s.d., n=5, per group. a,bValues in the same column with different superscripts are significantly different at P<0.05.
 
Table 7.
Effects of an aqueous extract of the leaves of S. liberica on ocular markers of oxidative stress in normal and alloxan treated rats.
Treatment group Ascorbic acid content
(毺mole/g protein)
Malondialdehyde content
(毺mol/g protein)
Catalase activity
(Units/mg protein)
Superoxide dismutase activity 
(Units/mg protein)
Normal 11.233依0.474a,e 0.091依0.001a 20.595依0.855a,f,g 0.196依0.001a
Test control   8.295依0.011c 0.098依0.001c 18.843依0.190c 0.157依0.002b
Reference   8.724依0.107d 0.074依0.001d 23.425依0.533d 0.182依0.001c
LLC1 11.666依0.312e 0.090依0.001a 22.298依0.576d 0.193依0.001d
LLC2 14.750依0.238f 0.086依0.003e 26.453依0.045e 0.209依0.000e
LLC3 12.582依0.096g 0.079依0.002f 21.220依0.238f 0.193依0.000d
LL1   9.889依0.073b 0.076依0.001d 19.628依0.076g 0.185依0.001f
LL2 12.462依0.022g 0.086依0.001e 20.537依0.050a 0.203依0.000g
LL3 10.744依0.073a 0.030依0.000b 24.933依0.084b 0.212依0.000h
Values are mean依s.d., n=5, per group. a,bValues in the same column with different superscripts are significantly different at P<0.05.
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higher (P<0.05) than those of all the other groups.
  The effects of an aqueous extract of the leaves of S. liberica 
on the atherogenic indices of normal and alloxan-induced 
diabetic rats is shown in Table 4. All the atherogenic indices 
(cardiac risk ratio, atherogenic coefficient and atherogenic 
index of plasma) of the test control group were significantly 
higher (P<0.05) than those of all the other groups. 
  The effects of an aqueous extract of the leaves of S. liberica 
on the levels of plasma markers of liver integrity and 
function in normal and alloxan-induced diabetic rats is 
given in Table 5. The plasma alkaline phosphatase and 
alanine transaminase activities of the test control group 
were significantly higher (P<0.05) than those of all the other 
groups. The plasma aspartate transaminase activity of the 
test control group was significantly higher (P<0.05) than 
those of control, LLC1, LLC2, LLC3, LL1 and LL2, but not 
significantly higher than those of reference and LLC3. The 
plasma total bilirubin level of the test control group was 
significantly higher (P<0.05) than all the other those groups, 
except reference and LL3. The plasma conjugated bilirubin 
level of the test control group was significantly higher 
(P<0.05) than all the other groups, except LL3. The plasma 
unconjugated bilirubin level of the test control group was 
significantly higher (P<0.05) than those of control, LLC1, 
LLC2, LL1, LL2 and LL3, but significantly lower (P<0.05) 
than reference and LLC3. Plasma unconjugated/conjugated 
bilirubin level of the test control group was significantly 
lower (P<0.05) than than those of reference, LLC3, LL1 and 
LL2, and significantly higher (P<0.05) than that of LL3, but 
not significantly different from those of control, LLC1 and 
LLC2. The plasma total protein concentration of the test 
control group was significantly lower (P<0.05) than that of 
LL2, but significantly higher (P<0.05) than those of all the 
other groups.
  The effects of an aqueous extract of the leaves of S. liberica 
on the plasma electrolyte profiles of normal and alloxan-
induced diabetic rats is shown in Table 6. The urea, blood 
urea nitrogen and sodium levels of the test control group 
were significantly higher (P<0.05) than those of all the other 
groups. The plasma bicarbonate and chloride levels of the 
test control group were significantly lower (P<0.05) than 
those of all the other groups. The plasma calcium level of 
the test control group was significantly lower (P<0.05) than 
those of all the other groups except reference. The plasma 
potassium level of the test control group was significantly 
lower (P<0.05) than those of all the other groups except 
LLC2.
  Table 7 shows the effects of an aqueous extract of the leaves 
of S. liberica on ocular markers of oxidative stress in normal 
and alloxan-induced diabetic rats. The ocular ascorbic 
acid content of the test control group was significantly 
lower (P<0.05) than those of all the other groups. The 
ocular malondialdehyde content of the test control group 
was significantly higher (P<0.05) than those of all the other 
groups. The ocular catalase and superoxide dismutase 
activities of the test control group was significantly lower 
(P<0.05) than those of all the other groups.
  The effects of an aqueous extract of the leaves of S. liberica 
on the hematological indices of normal and alloxan-induced 
diabetic rats is presented in Table 8. The hematocrit, 
hemoglobin concentration and neutrophil count of the test 
control group was significantly lower (P<0.05) than those of 
all the other groups. The red cell count of the test control 
group was significantly lower (P<0.05) than those of reference 
and LLC3, and significantly higher (P<0.05) than those of 
LLC1, LLC2, LL1, LL2 and LL3, but not significantly different 
from control. The total white cell and lymphocyte counts of 
the test control group were significantly higher (P<0.05) than 
those of all the other groups. The monocyte count of the test 
control group was significantly higher (P<0.05) than those 
of all the other groups, except the control and reference 
that were not significantly different and significantly 
Table 8.
Effects of an aqueous extract of the leaves of S. liberica on the hematological indices of normal and alloxan treated rats.
Parameter
Magnitude
Normal Test control Reference LLC1 LLC2 LLC3 LL1 LL2 LL3
Hematocrit (%) 34.4依0.9a 31.0依1.0c 38.8依0.8d   45.8依0.4e   45.8依0.8b,e 47.5依0.5f   46.7依0.4b 46.0依0.7b,e   46.7依0.4b,f
Hemoglobin concentration (g/
dL)
12.0依0.1a 11.4依0.2b 12.3依0.4a   13.1依0.1c   13.9依0.1d 14.6依0.1e   14.3依0.0f 14.1依0.0g   13.8依0.1d
Red cell count (×109 cells/L)   5.7依0.4a,c   5.5依0.0c   6.7依0.3d     4.3依0.1e     4.3依0.1e   6.0依0.2a     4.3依0.4e   5.1依0.1b     4.2依0.1e
Total white cell count (×109 
cells/L)
  9.7依0.4a 12.0依0.3c 10.2依0.2d     4.4依0.1e     4.5依0.1e   8.4依0.6b     7.8依0.1b   7.0依0.1f     7.2依0.5b,f
Neutrophils count (%)   5.3依0.4a   3.7依0.5b   5.5依0.5a   52.8依0.9c   53.0依1.2c 42.7依0.9d   33.3依0.8e 30.3依0.4f   31.0依0.7f
Lymphocytes count (%) 81.7依0.5a 83.3依0.5b 77.5依0.5c   44.8依0.8d   42.3依0.8e 51.6依0.6f   65.0依1.4g 66.7依0.9h   68.0依0.7h
Monocytes count (%) 12.8依1.1a 12.8依0.8a 15.6依1.1b     1.8依0.3c     2.5依0.1d   5.2依0.1e     1.6依0.1c   1.3依0.1f     0.7依0.1g
Eosinophils count (%)   0.0依0.0a   0.0依0.0a   0.0依0.0a     0.4依0.1c,e     0.8依0.2b,d,f   0.5依0.1d,e     0.0依0.0a   1.0依0.1b     0.3依0.1c,f
Basophils count (%)   0.0依0.0a   0.0依0.0a   0.0依0.0a     0.4依0.0b     0.2依0.1c   0.0依0.0a     0.0依0.0a   0.4依0.0b     0.0依0.0a
Mean cell volume (fL) 60.1依3.8a 56.4依1.6c 57.9依2.1ac 107.1依3.5d 107.1依2.5d 79.4依2.5e 108.5依10.4d 89.7依3.2b 110.3依3.7d
Mean cel l  haemoglobin 
concentration (g/dL)
34.8依1.1a 36.7依1.5a 31.8依0.4c   28.6依0.4d   30.4依0.6b,e 30.7依0.4b   30.6依0.3b 30.7依0.4b   29.6依0.2e
Mean cell haemoglobin (pg/
cell)
2.1依0.2a   2.1依0.0a   1.8依0.1c     3.1依0.1d     3.3依0.1e   2.4依0.1f     3.3依0.3d,e   2.8依0.1b     3.3依0.1e
Values are mean依s.d., n=5, per group. a,bValues in same row with different superscripts are significantly different at P<0.05.
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higher (P<0.05) respectively. The mean cell hemoglobin 
concentration of the test control group was significantly 
higher (P<0.05) than those of all the other groups, except 
the control that was not significantly different. The mean 
cell hemoglobin of the test control group was significantly 
lower (P<0.05) than those of all the other groups, except the 
control and reference that were not significantly different 
and significantly lower (P<0.05) respectively. The mean 
cell volume of the test control group was significantly 
lower (P<0.05) than those of all the other groups, except the 
reference that was not significantly different. There were no 
significant differences in the eosinophil and basophil counts 
of all the groups.
4. Discussion
  Diabetes mellitus induced by alloxan, is usually 
characterized by decreased insulin level, hyperglycemia, 
elevated triglycerides and total cholesterol, and decreased 
high density lipoprotein[31]. The high percentage reduction 
in plasma glucose levels, produced by the extract in this 
study, supports the use of the plant in the management of 
diabetes mellitus. The hypoglycemic effect of the extract 
may have been produced by the flavonoids, saponins and 
tannins present in the leaves[5,7]. The flavonoids, saponins 
and tannins are families of compounds with established 
hypoglycemic activity[32-37]. Thus, anyone or a combination 
of some or all of the above mentioned components could 
have been responsible for the hypoglycemic effect of the 
extract, observed in this study. 
  Elevated levels of plasma triglyceride, is both an 
independent and synergistic risk factor for cardiovascular 
diseases[38-40]. It is often associated with hypertension[41,42], 
abnormal lipoprotein metabolism, obesity, insulin resistance 
and diabetes mellitus[40,43,44]. The treatments significantly 
reduced plasma levels of triglycerides. This effect may have 
been mediated by the flavonoid[5] and vitamin C[6] contents 
of the leaves; since flavonoids[45] and vitamin C[46-48] are 
known to decrease plasma triglyceride levels.
  The administration of the extract produced significantly 
higher plasma HDL cholesterol levels. This portends 
reduction of cardiovascular risk; since increases in plasma 
HDL cholesterol concentration are known to decrease 
cardiovascular risk[49,50].
  Elevated plasma total cholesterol level is a recognized and 
well-established risk factor for developing atherosclerosis 
and other cardiovascular diseases[51], and is found in 
diabetes mellitus. Therefore, a reduction in plasma total 
cholesterol level reduces the risk of cardiovascular diseases. 
Consequently, the dose dependent reduction in plasma 
total cholesterol levels produced by the extract, connotes 
the ability of the extract to protect against cardiovascular 
complications. 
  Elevated levels of plasma VLDL cholesterol is a risk 
factor for cardiovascular disease[51,52] and often found in 
the diabetic[18,44,50] and obese[53] individuals. In this study, 
a significantly lower plasma VLDL cholesterol levels was 
observed in the treated animals compared to control. This 
is an indication of the cardio-protective potential of the 
extract.
  Raised plasma level of LDL cholesterol is a risk factor 
for cardiovascular disease[51,52] and often accompanies 
hypertension[54,42] and diabetes mellitus. Conversely, 
reductions in plasma LDL cholesterol have been considered 
to reduce risk of coronary heart disease[44,50]. In this study, 
a significantly lowered plasma LDL cholesterol levels was 
observed in the animals given the extract, suggesting the 
likely cardio-protective effect of the extract. 
  Many studies have shown that non-HDL cholesterol is a 
better predictor of cardiovascular disease risk than LDL 
cholesterol[18,55,56]. Therefore, the significantly lower plasma 
non HDL cholesterol observed in the treated diabetic groups 
is another indicator of the ability of the extract to reduce 
cardiovascular risk.  
  This hypocholesterolemic effect of the extract may be 
due to the leaves’ content of flavonoids, saponins and 
tannins[5,7], which are known to have cholesterol lowering 
and atheroprotective activities[35,57,58,59]. Again, anyone 
or a combination of some or all of the above mentioned 
components could have been responsible for the 
hypocholesterolemic effect of the extract, observed in this 
study.
  Atherogenic indices are powerful indicators of the risk of 
heart disease: the higher the value, the higher the risk of 
developing cardiovascular disease and vice versa[38,39,60,61]. 
Low atherogenic indices are protective against coronary 
heart disease[61]. This again highlights the ability of the 
extract to protect against cardiovascular complications in 
the diabetic.
  These results show that the extract had a dose dependent 
positive effect on the integrity and function of the liver 
and kidney of the diabetic rats. It improved the lowered 
plasma calcium level produced by the diabetic condition. 
The extract may have achieved this by affecting parathyroid 
hormone secretion. This hormone increases the renal 
tubular re-absorption of calcium, promotes intestinal 
calcium absorption[62,63]. The significance of this cannot be 
overemphasized. Many neuromuscular and other cellular 
functions are dependent on the maintenance of the ionized 
calcium concentration in the extracellular fluid[63]. Calcium 
fluxes are also important mediators of hormonal effects 
on target organs through several intracellular signaling 
pathways, such as phosphoinositide and cyclic adenosine 
monophosphate systems[63,64].
  Reduced erythrocyte and plasma potassium concentrations 
have been associated with glucose intolerance. Potassium 
depletion causes glucose intolerance, which is associated 
with impaired insulin secretion[65]. Therefore, the alleviation 
of the diabetes induced reduction in plasma potassium 
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levels portends ability of the extract to improve insulin 
activity. The treatment also alleviated the diabetes induced 
metabolic acidosis in the test animals.
  Induction of diabetes in rats with alloxan usually results 
in an increase in thiobarbituric acid reactive substances, an 
indirect evidence of intensified free-radical production[66]. 
Increased levels of these thiobarbituric acid reactants 
are consistently observed in diabetes[67-74]. Increases in 
blood and tissue levels of thiobarbituric acid-reactive 
substances, mainly malondialdehyde, are very reliable 
indices of oxidative stress and lipid peroxidation[69,75]. Thus 
the profiles of malondialdehyde seen in the test rats clearly 
indicate that the extract protects against oxidative stress 
in ocular tissues. This antioxidant protective effect may be 
due to the presence of flavonoids and tannins in the leaves. 
Both families of compounds have established antioxidant 
activities[35,36,45,57,59]. 
  Reduced levels and altered metabolic turnover of 
ascorbic acid have been reported in diabetic patients[69,74]. 
According to Samuel et al[74], the high extracellular glucose 
concentration in the diabetic impairs the cellular uptake 
of ascorbic acid, and accentuates the problems which are 
associated with its deficiency. Studies show that ascorbic 
acid protects the lens and other tissues of the eye from light 
damage[76,77]. So, the high ocular ascorbic acid levels caused 
by the extract, portends a consolidation of antioxidant status 
of the eyes, hence protection of its tissues from free radical 
damage. This correlates with the observed reduction in the 
level of lipid peroxidation. This increase in ascorbic acid 
content of the eyes of the test animals may have resulted 
from the high ascorbic acid content of the leaves[6].
  In diabetics, reduced activities of the antioxidant enzyme 
systems often results from the progressive glycation of the 
enzymatic proteins[68,69,74]. Many studies have reported 
variations in the levels of antioxidants in the diabetic 
patients[68,74]. In this study, the treatment improved the 
ocular activities of catalase and superoxide dismutase of the 
animals. 
  The extract had a positive effect on the hemopoietic system 
of the test rats. It significantly increased the hematocrit, 
hemoglobin concentration, neutrophil and monocyte counts 
while decreasing total white cell and lymphocyte counts. 
White blood cells play important roles in the destabilization 
of coronary artery plaques at the onset of acute coronary 
syndrome[78-80]. Nevertheless, an elevated white blood cell 
count in peripheral blood is a known risk factor of coronary 
artery disease[81]. Therefore, the lower total white blood 
cell count, observed in the test rats, is an indication of the 
ability of the extract to protect against diabetes induced 
increases in total white cell count. It also means reduction of 
the risk of coronary artery disease. The decreased white cell 
count may have been produced by the immune-modulating 
activity of saponins[35,82] and tannins[83], present in the 
leaves of S. liberica.
  This study showed that the extract was hypoglycemic, 
positively affected the hemopoietic system, and integrity 
and function (dose dependently) of the liver and kidney 
of the diabetic rats; improved the lipid profile and had no 
deleterious effect on red cell morphology. The profiles of 
malondialdehyde and antioxidant vitamins in the test rats 
clearly indicate that the extract protects against oxidative 
stress in ocular tissues. All of these, highlight the cardio-
protective potential of the leaves of S. liberica, and 
support its use in traditional health care practices for the 
management of diabetes mellitus.
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